Search

everythinglearnresearchcommunity

for

Search:↓

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Stopping finasteride improves sperm quality but not semen volume in young men.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Cuscuta reflexa extract may help treat hair loss caused by hormones.

Hair loss in women may have causes other than hormones.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

New compounds were made that are promising for prostate cancer therapy.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.